The chemiluminescence immunoassay market size is estimated to reach US$ 10.6 billion by the end of 2027, registering a CAGR of 7.6% from 2020 to 2027. The report provides the overall revenue of the global chemiluminescence immunoassay market from 2016 to 2027, considering 2020 as the base year and 2027 as the forecast year.
Immunoassays form an imperative section in diagnostics which mostly deal with scrutinizing antigen-antibody reaction. The spectrum of tests that is analyzed with the help of this technology is widespread and analyzers underneath this technology form the mainstay of clinical chemistry testing. Chemiluminescent immunoassay (CLIA) is a variation of the biochemical technique employed in immunology named standard enzyme immunoassay. They can also be utilized as diagnosis tools in medicine and further finds application in several other plentiful industries. The foremost benefit of this technology comprises sensitivity and its aptitude to be unpretentious by signals in the background. Correspondingly, the analyzers working below this principle are easier in operation and design.
We customize your report according to your research need. REQUEST CUSTOMIZED COPY OF REPORT (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/customization/1165
- North America led the global market in 2019 with largest market share on account of snowballing occurrence of chronic diseases and better-quality and upgraded healthcare infrastructure
- Asia Pacific is prospective to be an extremely rewarding market for the chemiluminescence immunoassay and it is anticipated to inflate at a high growth rate throughout the prediction period
- Hospitals segment reported highest share of the revenue generated in 2019. This growth is attributed to snowballing number of uses of automated CLIA analyzers in oncology, therapeutic drug monitoring and companion diagnostics
- Emergence of integrated modules of automated CLIA analyzers is prospective to flourish the growth of hospitals segment throughout the estimate period
Enhancements are predictable during years to come with the progress of novel analytical platforms like 2D resolution for chemiluminescence multiplex immunoassay and flow-injection chemiluminescent immunoassay and magnetic nanoparticles chemiluminescence immunoassay. This would probably outcome in supplementary increases in the clinical effectiveness of antibody tests. Influences like intensifying pervasiveness of infectious and chronic diseases, technological progressions in POC testing products, and mounting patient consciousness of POC testing are few of the chief influences fueling the need of immunoassay depending upon POC testing and swift testing around the world. The chemiluminescence immunoassay analyzers market is presently a thriving one, as there has been upsurge in requirement for laboratory automation and alliance to attain competence and precision. Many aspects including great parameters testing in small period of time, huge sample processing capacity, least labor necessity, more throughput, integrated data storage and quality control, integrated validation facility with an aim to advance complete effectiveness and accuracy of tests with decreased incubation period is expected to accelerate the growth of the market throughout the prediction period.
The COVID-19 epidemic has further intensified outlook for the chemiluminescent immunoassay market. Expansion of a peptide-based magnetic CLIA for serological diagnosis is underneath way to that effect. Thus, the global chemiluminescent immunoassay market is predicted to relish an optimistic growth trajectory.
Report Scope of the Chemiluminescence Immunoassay Market
|Market Size||USD 10.6 Billion by 2027|
|Growth Rate||CAGR of 7.6% from 2021 to 2027|
|Largest Market||North America|
|Fastest Growing Market||Asia Pacific|
|Forecast Period||2021 to 2027|
|Segments Covered||Product Type, Application Type, End User Type, Region Type|
|Companies Mentioned||B. Braun Melsungen AG, Merck KGaA, Thermo Fisher Scientific, Inc., Baxter International, Inc., Intermountain Life Sciences, Cytiva (Danaher), Standard Reagents, Pvt. Ltd., FUJIFILM Irvine Scientific, CovaChem, LLC, Pfizer, Inc and Fresenius Kabi AG.|
Geographically, North America led the global CLIA market in 2019 and this tendency is predicted to endure throughout the assessment duration. Noteworthy average selling prices of automated CLIA analyzers, mountingneed from surgeons for technically innovative diagnostic instruments with improved accuracy and specificity, and promising coverage as per the Clinical Laboratory Improvement Amendments for IVD procedures are some of the crucial influences predicted to flourish the growth of the market across the region.
Asia Pacific is set to record exponential progress during near future. Steady implementation of innovative products including CLIA technologies, augmented healthcare spending, intensifying rivalry amongst market players and nationwide and intercontinental authorizations to found new laboratories are crucial growth drivers supporting the growth of the market in Asia Pacific.
Certain substantial participants operating in the chemiluminescence immunoassay market include:
- Hoffmann-La Roche AG
- Siemens Healthineers
- Abbott Laboratories
- DiaSorin S.p.A.
- Ortho Clinical Diagnostics
- Immunodiagnostic Systems
- Beckman Coulter Inc.
- Inova Diagnostics, Inc.
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Maccura Biotechnology Co., Ltd
Segments Covered in the Report
This research report includes complete assessment of the market with the help of extensive qualitative and quantitative insights, and projections regarding the market. This report offers breakdown of market into prospective and niche sectors. Further, this research study calculates market revenue and its growth trend at global, regional, and country from 2016 to 2027.This report includes market segmentation and its revenue estimation by classifying it on the basis of product, application, end-usersand region as follows:
- Software & Services
- Therapeutic Drug Monitoring
- Autoimmune Disease
- Infectious Disease
- Clinical Laboratories
- Pharmaceutical & Biotechnology Companies
By Regional Outlook
- North America
- Rest of EU
- Asia Pacific
- Southeast Asia
- Rest of APAC
- Middle East & Africa
- North Africa
- South Africa
- Rest of Middle East and Africa
- Latin America
- Rest of Latin America
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Why Buy this Report?
The purpose of Precedence Research’s chemiluminescence immunoassay market study is to provide stakeholders with a detailed picture of potential barriers and untapped opportunities. The report contains exclusive information to assist businesses in making informed decisions about how to maintain growth throughout the assessment period.
Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1165
Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace &defense, among different ventures present globally.
Call: +1 9197 992 333